Amorfix Life Sciences Ltd. is a product development company focused on therapeutic antibodies and diagnostics for the diagnosis and treatment of misfolded protein diseases including amyotrophic lateral sclerosis (ALS), cancer and Alzheimer’s disease (AD). The Company is offering two types of products: Therapeutics and Diagnostic Services. The Company's Therapeutics is designed to target and neutralize only the misfolded conformation of a given protein. The Company provides Diagnostic Services using its sensitive and specific Diagnostic Kits to Alzheimer's researchers and prion removal equipment manufacturers. The Company’s product line include ALS Therapeutic Antibody and ALS Therapeutic Vaccine; ALS Diagnostic Test; AD Preclinical A, AD Clinical EP-AD CSF Test; Anti-PrP (ovarian cancer), Anti-Fas (melanoma) and Anti-CD38 (myeloma/leukemia), and Cangene-Amorfix Collaboration.